STOCK TITAN
  1. Home
  2. Sec-filings
  3. MCHX
  4. [Form 4] MARCHEX INC Insider Trading Activity

MCHX Form 4: 150,000 RSUs and options granted to COO & CLO

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Marchex (MCHX) reported an insider equity grant to its Chief Operating Officer & CLO. On 10/16/2025, the executive received 150,000 restricted stock units, each settling into one share of Class B Common Stock, vesting in full on the fourth anniversary of the grant date.

On the same date, the executive was also granted 150,000 stock options with a $1.81 exercise price, expiring on 10/16/2035. The options vest over four years: 25% on the first anniversary, then quarterly in equal 6.25% increments over the next three years.

Positive

  • None.

Negative

  • None.
Insider Feeney Francis J
Role Chief Operating Officer & CLO
Type Security Shares Price Value
Grant/Award Restricted Stock Units 150,000 $0.00 --
Grant/Award Employee Stock Option (right to buy) 150,000 $0.00 --
Holdings After Transaction: Restricted Stock Units — 150,000 shares (Direct); Employee Stock Option (right to buy) — 150,000 shares (Direct)
Footnotes (1)
  1. Restricted stock units award effective October 16, 2025 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the fourth anniversary of the Grant Date. Stock options award effective October 16, 2025 (the "Grant Date"), with vesting over four years, 25% of the total option shares vesting on the first anniversary of the Grant Date and the remainder vesting quarterly thereafter over the next three (3) year period in equal increments of 6.25% of the aggregate amount of such shares, subject to acceleration of vesting in certain events.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feeney Francis J
(Last) (First) (Middle)
1200 5TH AVE
SUITE 1300
(Street)
SEATTLE WA 98101
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARCHEX INC [ MCHX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer & CLO
3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/16/2025 A 150,000 (1) (1) Class B Common Stock 150,000 $0 150,000 D
Employee Stock Option (right to buy)(2) $1.81 10/16/2025 A 150,000 (2) 10/16/2035 Class B Common Stock 150,000 $0 150,000 D
Explanation of Responses:
1. Restricted stock units award effective October 16, 2025 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the fourth anniversary of the Grant Date.
2. Stock options award effective October 16, 2025 (the "Grant Date"), with vesting over four years, 25% of the total option shares vesting on the first anniversary of the Grant Date and the remainder vesting quarterly thereafter over the next three (3) year period in equal increments of 6.25% of the aggregate amount of such shares, subject to acceleration of vesting in certain events.
/s/ Francis J Feeney 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR